Skip to main content

Division of Allergy and Immunology News

Our experts in the Division of Allergy and Immunology take a team approach to your child's care. This allows us to respond to your questions and concerns as quickly as possible.

Appointments and referrals

In the Journals: Nirsevimab

Jan 18, 2024

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top